Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN133,74133,881,53
Msft1,63
Nokia10,50510,61,83
IBM0,53
Mercedes-Benz Group AG49,58549,5851,70
PFE-1,39
02.05.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 01.05.2026
CryoLife (CRY, NY Consolidated)
Závěr k 1.5.2026 Změna (%) Změna (USD) Objem obchodů (USD)
36,21 1,06 0,38 6 499 721
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace:
Popis společnosti

Business Summary: Artivion, Inc. is engaged in manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The Company operates through two segments, which include Medical Devices and Preservation Services. The medical devices and preservation services are primarily used by cardiac and vascular surgeons to treat patients with aortic disease, including heart valve disease, aortic aneurysms, and dissections, and, to a lesser extent, other conditions in cardiac and vascular surgery. It has four product families: aortic stent grafts, On-X mechanical heart valves and related surgical products, surgical sealants, and implantable cardiac and vascular human tissues. Its aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Its surgical sealants include BioGlue Surgical Adhesive products.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, Artivion Inc revenues increased 14% to $441.3M. Net income applicable to common stockholders totaled $9.8M vs. loss of $13.3M. Revenues reflect Medical devices segment increase of 19% to $345.8M, International segment increase of 14% to $227.3M, United States segment increase of 13% to $214.1M. Net Income reflects Other (income) expense, net - Balancing increase from $15.3M (expense) to $18K (income).



  • Poslední aktualizace:
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Supervisory BoardBogdan Benczak-14.11.202514.11.2025
President of the Management Board of the Bank, Chief Executive OfficerCezary Stypulkowski7005.10.202405.10.2024
Independent Deputy Chairman of the Supervisory BoardArtur Nowak-Far-22.04.202422.04.2024
Vice President of the Management Board of the Bank - Supervising the Risk Management MaterialMarcin Gadomski-29.11.2019
Vice President of the Management Board of the Bank - Supervising Corporate BankingLukasz Januszewski4701.09.202501.09.2025
Vice President of the Management Board of the Bank - Supervising Integrated Channels, Products, and Retail Segments DivisionMichal Panowicz-01.09.202501.09.2025
Vice President of the Management Board of the Bank - Supervising Corporate Banking, Markets, and Investment Banking DivisionRobert Sochacki-09.07.2024
Vice President of the Management Board of the Bank - Supervising the Branch Distribution, Private Banking, and Operations DivisiBlazej Szczecki-15.01.2021
Vice President of the Management Board of the Bank - Supervising the Operations of the Financial DivisionDagmara Wojnar-18.07.202418.07.2024